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                                         INTRODUCTION 
 
Thyroid surgeries are usually performed under general anaesthesia, but can 
be successfully performed under regional anaesthesia
1 
too. A deep plane of 
General anaesthesia is usually due to the combination of surgical procedure 
and tracheal stimulation due to the movement of endotracheal tube during 
surgery. Recovery may be delayed due to deep anaesthesia. So the short 
acting opioids can be used, but post operative hyperalgesia is a major 
disadvantage. 
Pain after thyroid surgery is mild to moderate intensity. Some patients may 
require opioid or NSAIDS for first 24 hours. In a study by Gozal et al
2
, the 
mean pain level on (VAS) was 6.9 and opiates were required in >90 % of 
patients. In addition to the pain, patient may have post operative nausea and 
vomiting
3
 following thyroid surgeries. 
Opioids can produce effective analgesia, but also produce unwanted side 
effects like nausea vomiting, urinary retention, somnolence and 
hypoventilation. These side effects may be attenuated by reducing the dose 
of opioids
4
, but the analgesic efficacy might then be less than optimal. 
Therefore various analgesic methods have been adopted like non-opioid 
analgesics, regional blocks
5
 and local anaesthetic infiltration at the wound 
site. 
Bilateral superficial cervical plexus block
6
 is a popular regional anaesthetic 
technique which may reduce the analgesic requirements. In a study
7
 using 
two point technique with bilateral superficial cervical plexus block  found  to 
be  effective, but three point technique
34
 still more improves analgesic effect 
of  bilateral superficial  cervical  plexus block. This technique was used in 
previous studies. In one study
8
 regional block was given without any 
adjuvant such as clonidine or epinephrine. Latter studies have proven that 
addition of clonidine increases the duration of analgesia. Danelli and 
colleagues
9
 reported that cervical plexus block performed using ropivacaine 
with clonidine improved the quality of anaesthesia and prolonged the 
duration of post operative analgesia.  
 This study was conducted in patients undergoing total thyroidectomy, to 
compare the post operative analgesic efficacy of Bilateral Superficial 
Cervical Plexus Block performed before the induction of general 
anaesthesia, with ropivacaine (0.5%) and ropivacaine (0.5%) with clonidine 
(2mcg/kg).The primary aim of our study is to evaluate the duration of post 
operative analgesic efficacy of these drugs.  
           The secondary objectives were to evaluate the intra operative opioids 
dosage, to assess intra and post operative hemodynamic responses, post 
operative pain scores and the time of rescue analgesia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                             AIM 
 
 
 
 
              To compare the  post operative analgesic efficacy of   ropivacaine 
(0.5%) and ropivacaine (0.5%) with clonidine (2mcg/kg) in bilateral  
superficial  cervical  plexus  block performed  prior to  general  anaesthesia  
for  thyroid surgeries. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                        
                              CERVICAL PLEXUS 
 
Formation: 
The cervical plexus
10
 is formed by the ventral rami of the upper four cervical 
nerves. The rami emerge between the anterior and posterior tubercles of the 
cervical transverse process. All the rami divide into two except first cervical 
nerve. The four roots are connected with one another to form three loops. 
Position: 
The cervical plexus lies on the surface of scalenus medius and levator 
scapulae muscle and deep to internal jugular vein and Sternomastoid muscle. 
Branches:  
 
A. Superficial branches emerge at the superficial fascia of the neck near the 
midpoint of the posterior border of sternomastoid muscle. 
 1. Lesser occipital nerve (C2) ascends at the posterior border of 
sternomastoid muscle. It supplies the skin of the upper neck and 
behind the auricle.  
 2. Great auricular nerve (C2, 3) ascends across sternomastoid muscle 
to reach the skin over the parotid region. It supplies the skin over the 
upper neck and parotid region.  
 3. Transverse cervical nerve (C2, 3) crosses sternomastoid 
horizontally and supplies the skin over the anterior triangle.  
 4. Supra clavicular nerves (C3, 4) descend behind the sternomastoid 
muscle and supply the skin over the shoulder and upper pectoral 
region. 
B. Deep branches: 
1. Muscular branches supply the muscles of the neck and phrenic nerve 
supplies diaphragm.  
 
2. Communicating branches: pass from the superior cervical ganglion, 
Hypoglossal nerve and Spinal accessory nerve 
SUPERFICIAL CERVICAL PLEXUS 
The superficial cervical plexus supplies the skin over the antero lateral 
aspect of the neck through anterior primary rami of C2 through C4. They 
emerge at the posterior border of the sternocleidomastoid muscle as four 
distinct nerves.  
The lesser occipital nerve is a branch from stem of C2.The remaining stem 
joins with the part of C3 to form a nerve trunk which divides into greater 
auricular and transverse cervical nerve. 
The remaining part of C3 runs downwards and joins with major part of C4 
and forms supra clavicular trunk which divides into upper, middle and lower 
supra clavicular nerves. 
Ascending branches: 
1. Occipitalis major 
2. Auricularis magnus 
3. Superficialis coli 
4. Supra sternal nerve 
Descending branches: 
1. Supra clavicular 
2. Supra acromial 
 
SUPERFICIAL CERVICAL PLEXUS BLOCK 
The patient is positioned supine
11
 with neck slightly turned to the opposite 
side and the posterior border of sternomastoid muscle is identified. 
TWO POINT TECHNIQUE:
12
 
A line is drawn from the mastoid process to Chassaignac`s tubercle of C6 
transverse process. A 23 gauge spinal needle is inserted at the midpoint of 
this line, a skin wheal is raised. The spinal needle is directed cephalad 
towards the mastoid process along the posterior border of sternomastoid in a 
subcutaneous plane and 2-3 ml of local anaesthetic is injected as the needle 
is withdrawn. Avoid piercing the external jugular vein. As the needle 
reaches the wheal, it is rotated 180` and directed subcutaneously caudad 
toward the clavicle along the posterior border of sternomastoid muscle. A 
similar amount of local anaesthetic is injected as the needle is withdrawn. 
THREE POINT TECHNIQUE: 
 Using three point injection
13
 technique 10 ml of prepared solution was 
injected in both sides of neck. 
A 23 gauge needle was inserted at the posterior border of 
sternocleidomastoid muscle, 2cm above the clavicle. The depth of the needle 
should be less than 5mm. 6ml of prepared mixture was given in cephalad 
direction, 2ml in the transverse direction. These two injections are to block 
the greater auricular and transverse cervical nerves. 2ml of injection given at 
the site of needle puncture to block the supraclavicular nerve14. Many 
studies have shown that this technique is more effective than the two point 
technique.   
Complications: 
1. Infection (if sterility is not maintained during the procedure). 
2. Hematoma formation. 
3. Phrenic nerve palsy. 
4. Local anaesthetic toxicity. 
5. Spinal anaesthesia (accidental). 
 
 
                                             
                                    
 
                                
 
                              THYROID GLAND 
 
ANATOMY: 
Thyroid gland is a butterfly shaped organ
15
, situated in the lower part of the 
front and sides of the neck. It regulates the basal metabolic rate, stimulates 
somatic and psychic growth, and plays an important role in calcium 
metabolism. 
The gland consists of right and left lobes that are joined to each other by an 
isthmus. A third pyramidal lobe may project upwards from the isthmus. The 
gland lies against vertebrae C 5, 6, 7 and T1clasping the upper part of the 
trachea. Each lobe extends from the middle of the thyroid cartilage to the 
fourth or fifth tracheal ring. 
The isthmus extends from the second to the third tracheal ring. 
Capsules of the thyroid: 
True capsule is the peripheral condensation of the connective tissue of the 
gland. 
The false capsule is derived from pretracheal layer of deep cervical fascia. 
 
 
 
Arterial supply: 
Superior thyroid artery: a branch of external carotid artery, divides into 
anterior and posterior branches. It supplies anterior and posterior border of 
lobes respectively. 
Inferior thyroid artery: a branch of the thyrocervical trunk which arises 
from the subclavian artery. 
Sometimes the thyroid gland is also supplied by the lowest thyroid artery 
(thyroidea ima artery) which arises from the brachio cephalic trunk or 
directly from the arch of aorta. 
Accessory thyroid artery arteries arising from tracheal and esophageal 
arteries also supply the thyroid. 
Venous drainage: 
The thyroid is drained by superior, middle and inferior thyroid veins 
Superior thyroid vein ends in the internal jugular vein or in the common 
facial vein. 
The middle thyroid vein: enters into the internal jugular vein. 
The inferior thyroid vein: enters into the brachio cephalic vein 
A fourth thyroid vein (of Kocher) may emerge between middle and inferior 
thyroid vein and drain into the internal jugular vein. 
 
Lymphatic drainage: 
Lymph from the upper part of the gland reaches upper deep cervical nodes 
either directly or through the pre laryngeal nodes. 
Lymph from the lower part of the gland drains to the lower deep cervical 
nodes directly, and also through the pre tracheal and para tracheal nodes. 
Nerve supply: 
Nerves are derived mainly from the middle cervical ganglion and partly also 
from the superior and inferior cervical ganglia. 
 
Structure and function: 
The thyroid gland is made up of two types of secretory cells
16
. Follicular 
cells lining the follicles of the gland secrete tri iodo thyronin and tetra iodo 
thyronin which stimulate basal metabolic rate and somatic psychic growth of 
the individual. 
Para follicular cells lie in between the follicles. They secrete thyro calcitonin 
which promotes deposition of calcium salts in skeletal and other tissues. 
Development: 
The thyroid develops
15
 from a median endodermal thyroid diverticulum 
which grows down in front of the neck and the floor of the primitive 
pharynx, just caudal to the tuberculum impar. The lower end of the 
diverticulum enlarges to form the gland. The rest of the diverticulum 
remains narrow and is known as the thyroglossal duct. 
 
                               
 
  
                      
 
 
Thyroid enlargement: 
The term goiter is used to describe generalized enlargement of the thyroid 
gland.  
Classification of thyroid swellings
17
: 
Simple goiter 
      Diffuse hyper plastic 
      Multinodular goiter 
Toxic 
      Diffuse 
      Multinodular 
     Toxic adenoma 
Neoplastic 
    Benign 
    Malignant 
Inflammatory 
    Auto immune 
           Chronic lymphocytic thyroiditis 
            Hashimoto`s thyroiditis 
 Granulomatous 
 Riedel`s thyroiditis 
Indication for surgery in thyroid swellings: 
  Neoplasia 
Toxic adenoma 
Pressure symptoms 
Cosmesis 
Thyroid operations: 
 
1. Total thyroidectomy=Bi total lobectomy +isthmectomy 
2. Subtotal thyroidectomy=Bi subtotal lobectomy + isthmusectomy 
3. Lobectomy= Unilateral total lobectomy +isthmusectomy 
 
 
 
 
 
 
 
 
 
 
 
 
  
                               ROPIVACAINE 
 
Ropivacaine is a long acting local anaesthetic agent
18
 belonging to amino 
amide group .It is structurally related to Bupivacaine, but it is a pure S-
enantiomer of 1-propyl-2c,6c-pipecoloxylidide
19
  ,developed for the purpose 
of reducing cardio toxicity and improving motor and sensory blockade and 
even more motor-sparing than bupivacaine. 
 
                               
Physio chemical and pharmaco kinetic profile 
 
 
 
 
 
 
Molecular weight  
 
274 
PKa 
 
8.1 
Partition co efficient  
 
2.9 
Mean uptake ratio  
 
1.8 
Protein binding  
 
94% 
Mechanism of action: 
 
Ropivacaine blocks impulse conduction in nerve fibers by reversible 
inhibition of sodium ion influx. It is less lipophilic than and does not 
penetrate large myelinated motor fibers. It acts on the pain transmitting A- α 
and C nerves rather than A- β fibers which are involved in motor function. 
 
Pharmacodynamics
20
: 
Central nervous and cardiovascular system effects
21
: 
Ropivacaine because of its less lipophylic and stereo selective properties has 
higher threshold for cardio toxicity and CNS toxicity. 
Other effects: 
           -Inhibits platelet aggregation 
           -Antibacterial activity-inhibits the growth of staphylococcus aureus, 
E.Coli and pseudomonas aeruginosa. 
Pharmacokinetics: 
The plasma concentration of ropivacaine depends on 
               -  Total dose administered  
               -  Route of administration. 
The absorption of ropivacaine from epidural space is complete. 
The half life is 14 minutes at initial phase and 4.2 hours at slower phase. 
Ropivacaine is bound to plasma proteins, mainly to alpha1 acid 
glycoprotein. The total plasma concentration of ropivacaine increases during 
continuous epidural infusion. 
It rapidly crosses the placenta during caesarian section
22
, however the total 
plasma concentration in foetal circulation is very low. 
Metabolism and excretion: 
Ropivacaine is mainly metabolized in the liver by aromatic hydroxylation by 
cytochrome P450 (CYP) 1A2 and N-dealkylation
22
. 
The excretion of ropivacaine is through the kidney and 86% of the drug is 
excreted through kidney after a intravenous injection. 
 
Tolerability: 
Ropivacaine is usually well tolerated in adults and paediatric patients 
irrespective of route of administration. 
Epidural ropivacaine for surgery produces dose dependant side effects 
similar to Bupivacaine. The cardiovascular toxicity also increases due to 
excessive absorption from peripheral nerve blocks and sudden intra venous 
injection. 
Ropivacaine is well tolerated in the foetus in women undergoing lower 
segment caesarean section. The most common side effects with ropivacaine 
were neonatal jaundice, bradycardia. 
Drug interactions: 
Ropivacaine is used with caution when using with other local anaesthetics or 
agents with similar amide groups because of additive toxic effects. 
1. Fluvoxamine-inhibitor of cytochrome P4501A2. It can interact with 
ropivacaine and increase the plasma level of ropivacaine when given 
concomitantly. 
2. Interact with Imipramine and theophylline which are metabolised by 
CYP1A2 via competitive inhibition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dosage: 
 
Indication Concentration% volume dose 
Surgical anaesthesia 
Lumbar epidural (Caesarean 
section) 
0.75 15-20 ml 113-50mg 
Lumbar epidural 0.75 15-25ml 113-188 mg 
Other surgery 1 15-20ml 150 200mg 
Thoracic 0.75 5-15ml 38-113 mg 
Intra thecal administration 0.5 3-4ml 15-20mg 
Peripheral nerve block 0.75 10-40ml 75-300 mg 
Field block 0.75 1-30 ml 7.5-225 mg 
Postoperative pain    
  Lumbar epidural (Continuous 
infusion) 0.2 6-10 mL/h 12-20 mg/h 
  Thoracic epidural (Continuous 
infusion) 0.2 6-14 mL/h 12-28 mg/h 
  Peripheral nerve block 
(Continuous infusion) 0.2 5-10 mL/h 10-20 mg/h 
  Field block† 0.2 1-100 mL 2-200 mg 
  Intra-articular injection 0.75 20 mL 150 mg 
Labour pain(lumbar epidural)    
  Bolus 0.2 10-20 mL 20-40 mg 
  Intermittent top-ups 0.2 10-15 mL 20-30 mg 
  Continuous infusion 0.2 6-14 mL/h 12-28 mg/h 
In Children    
  Caudal epidural block (Below 
T12) 0.2 1 mL/kg 2 mg/kg 
  Peripheral nerve block (Eg, 
ilioinguinal block) 0.5 0.6 mL/kg 3 mg/kg 
 
 
 
 
 
 
 Clinical applications: 
The efficacy
23
 of ropivacaine has been evaluated by various clinical trials 
and compared with Bupivacaine and its isomers. 
1. Surgical anaesthesia: 
Ropivacaine is an effective anaesthetic when administered via epidural, intra 
thecal and peripheral nerve blocks. 
Epidural ropivacaine: 
Ropivacaine is mainly administered via lumbar route and used for caesarean 
section, gynecological surgeries, various abdominal procedures, orthopaedic 
surgery and vascular surgery. In the latter procedures, it is mainly used for 
post operative pain relief. 
2. Intra thecal administration: 
Intrathecal ropivacaine 
Ropivacaine is administered at higher doses for intrathecal administration 
than bupivacaine. Hyperbaric solutions of ropivacaine have a faster onset of 
action and faster recovery from the block and it provides a more predictable 
block. 
 
 
3. Peripheral nerve blocks: 
Peripheral nerve blocks are used for orthopaedic surgeries. Ropivacaine 
0.5% provides sensory and motor block for inter scalene, brachial plexus and 
axillary block for hand and arm surgery. Ropivacaine 0.75% had faster onset 
of action for femoral, sciatic and combined femoral and sciatic block for 
lower limb surgeries. 
4.  Post operative pain management: 
Epidural ropivacaine
24
 is used for post operative pain relief in upper and 
lower abdominal surgeries, lower limb, orthopaedic and gynecological 
surgeries.  
5. Management of labour pain: 
Epidural ropivacaine is used for labour analgesia
25
. 
Dose: Ropivacaine0.2% 10-20 ml bolus with intermittent top up injections 
(20-30mg) / continuous epidural 6-10ml/hr
26
. 
The addition of fentanyl
27
 2mcg/ml to 0.1% ropivacaine (10ml/hr) 
significantly reduces ropivacaine concentration and the quality of analgesia 
is equal to ropivacaine 0.2% solution. Addition of clonidine
9
 also 
significantly increases the duration of action of ropivacaine. 
 
 
6. Chronic pain management: 
Ropivacaine is used in management of chronic low back pain
28
 and as a 
palliative procedure in the management of refractory migraine
29
. 
 
                                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                          CLONIDINE 
 
Clonidine is an imidazoline derivative
30
 having complex actions. It is a 
partial agonist with high affinity to alpha 2 receptors especially alpha 2A 
subtype. 
 
                                    
 
Mechanism of action 
18
: 
Alpha2 adrenergic agonists produce clinical effects by binding to alpha2 
receptors which have three subtypes (α2A, α 2B, α 2C). 
Alpha2A receptors mediate sedation and sympatholysis. Alpha2B receptors 
mediate vasoconstriction. 
The alpha2 receptors are present in the pontine locus cereleus. Clonidine 
stimulates alpha2 adrenergic neurons in the medulla to cause a decrease in 
sympathetic outflow to peripheral tissues from the central nervous system. A 
decrease in sympathetic activity causes peripheral vasodilatation and a 
decrease in blood pressure, heart rate and cardiac output. 
The alpha2 receptors in the blood vessels produce vasoconstriction and 
inhibit the neither release of nor adrenaline at peripheral sympathetic 
nervous system nerve endings. 
 It is a moderatively potent antihypertensive agent. The quality of sedation 
produced by clonidine differs from that produced by drugs that act on 
GABA receptors (Midazolam, propofol). 
 
Pharmacokinetics
30
: 
Clonidine is well absorbed orally
31
. Effect of a single dose lasts for 6-24 hrs 
and peak effect occurs in 2-4 hrs. Up to 50% is metabolized in the liver and 
1/2 to 2/3 of oral dose is excreted unchanged in urine. 
Dose: 
Start with 100mcg o.d or bid. Maximum dosage: 300mcg tds orally or i.m. 
Transdermal form: 
 Catapres TTS delivers clonidine 100mcg, 200mcg or 300mcg daily 
for 1 week 
Parenteral form: 
 Clonidine hydrochloride 150mcg/ml ampoule 
 
 
Effects on organ systems: 
Cardio Vascular Effects: 
Clonidine decreases systolic blood pressure more than diastolic blood 
pressure. In patients treated over a long period of time, systemic vascular 
resistance is little affected, and cardiac output which is initially decreased, 
returns toward predrug levels. Homeostatic cardiovascular reflexes are 
maintained, thus avoiding the problems of orthostatic hypotension. In 
clonidine therapy, renal blood flow and glomerular filtration rate are 
maintained. 
Respiratory effects: 
Clonidine has minimal depressant effects on ventilation. Morphine induced 
depression of ventilation is not potentiated by clonidine. 
Central nervous system: 
Sedation and anxiolysis are the most consistent effects mediated by 
central alpha 2 receptors. Clonidine is a potent analgesic and its action that 
cannot be reversed by naloxone, indicating that analgesic effect of clonidine 
and opioid through independent receptor mechanisms. There is a 50% 
decrease in MAC of inhalational anesthetics and decreased anesthetic 
requirements of opioids. It also prevents shivering.  
 
  
 
 
 
 
 
 
 
 Clonidine is also effective in suppressing signs and symptoms of 
withdrawal from opioids, benzodiazepines and ethanol 
 
Adverse effects
31
: 
Side effects with clonidine are relatively common. 
1. Sedation, mental depression, disturbed sleep, dryness of mouth, nose and 
eyes (secretion decreased by central action) and constipation (antisecretory 
effect on intestine). 
2. Impotence, salt and water retention, bradycardia due to reduced 
sympathetic tone.  
3. Postural hypotension may occur but it is mostly asymptomatic. 
4. Alarming rise in BP with tachycardia, restlessness, anxiety, sweating, 
headache, nausea and vomiting occur in some patients when clonidine doses 
are missed for 1-2 days. The syndrome is very similar to that seen in 
phaeochromocytoma. Plasma catecholamine concentration was increased. 
This is due to 
  a) Sudden removal of central sympathetic inhibition resulting in release of 
large quantities of stored catecholamine. 
 b) Super sensitivity of peripheral adrenergic structures to catecholamines 
that develops due to chronic reduction of sympathetic tone during clonidine 
therapy. 
Interactions: 
Tricyclic anti depressants and chlorpromazine abolish the antihypertensive 
action of clonidine by blocking alpha receptors by which clonidine acts. 
USES: 
1. Antihypertensive: 
Clonidine was a popular antihypertensive drug in the late 1960s and 1970s, 
but frequent side effects, risk of withdrawal hypertension and development 
of tolerance made it as a third or fourth drug of choice. 
2. Analgesia: 
Clonidine injected into the epidural or sub arachnoid space (150-450mcg) 
produce analgesia but unlike opioids does not produce depression of 
ventilation, nausea, vomiting and delayed gastric emptying. 
Clonidine (1mcg/kg) added to lignocaine is used for TIVA. It enhances post 
operative analgesia. 
3. Pre anaesthetic medication: 
Oral clonidine 5mcg/kg 
 a) Blunts reflex tachycardia during intubation. 
b) Decreases BP and heart rate intra operatively. 
C) Decreases anaesthetic requirements of injected and inhaled drugs. 
d) Decreases plasma noradrenalin levels. 
4. Prolonging the effects of regional anaesthesia: 
Addition of clonidine to Bupivacaine or other local anaesthetics for spinal 
anaesthesia prolongs the duration of both sensory and motor blockade
41
. 
The need for infusion of fluids and decrease in diastolic pressure may be 
greater in patients receiving local anaesthetics with clonidine.   
Clonidine has been used by spinal, epidural, parenteral, intra articular 
and perineural routes to supplement postoperative analgesia produced by 
local anesthetics. 
5. Central nerve blocks: 
Clonidine produces dose dependent analgesia when administered into 
the epidural or subarachnoid space. Activation of post synaptic receptors in 
substantia gelatinosa of the spinal cord is the presumed mechanism for 
analgesic effect in central neuraxial blockade. 
Epidural or intrathecal clonidine is not neurotoxic, with large doses of 
epidural clonidine to achieve long term analgesia, side effects like sedation, 
hypotension and bradycardia are common. Thus epidural clonidine is usually 
used with opioids or local anaesthetics for post operative analgesia (10-
15mcg/kg) to avoid side effects.   
The maximum dose of intrathecal clonidine with local anaesthetics is 
1 mcg /kg and it improves the duration and quality of the block. 
In children Caudal clonidine is combined with local anesthetics to 
increase the duration of anesthesia without hemodynamic side effects. The 
dose of clonidine is 2 and 3 µg/kg. 
6. Peripheral nerve blocks: 
Clonidine is usually used as an adjuvant to local anesthetics in 
peripheral nerve blocks to prolong the duration of analgesia and anesthesia. 
It improves the quality of analgesia after surgery over 24 hours for some 
extremity blocks.  
The addition of clonidine to lignocaine improves the quality of 
intravenous regional anesthesia and tolerance of the tourniquet. 
7. Protection against perioperative myocardial ischemia: 
Clonidine decreases mortality following cardiovascular surgery by 
decreasing the incidence of myocardial ischemia and infarction. 
Clonidine 0.2mg at the morning or evening before surgery in patients at risk 
of CAD and continued for four days decrease the incidence of perioperative 
myocardial ischemia. 
8. Treatment of shivering: 
Administration of clonidine 75mcg iv stops shivering by inhibiting central 
thermoregulatory control. 
 9. Diagnosis of phaeochromocytoma 
10. Treatment of opioid and alcohol withdrawal syndromes. 
11. Attenuates vasomotor symptoms of menopausal syndrome 
12. To control loose motions due to diabetic Neuropathy 
Contraindications  
Disorders of cardiac impulse generation and conduction like sino- 
atrial disease, atrioventricular node disease and patients with cardiac 
pacemakers. 
           
 
 
 
 
 
 
 
 
                       ASSESSMENT OF PAIN 
 
Pain is a subjective and highly personal phenomenon unique to the 
individual. The definition of pain is ‘an unpleasant sensory and emotional 
experience associated with actual or potential damage or described in terms 
of such damage’ 
Acute pain is relatively straightforward to assess as, unlike chronic 
pain, it generally bears a predictable relationship to obvious tissue damage. 
Because the level of postoperative pain tends to change rapidly throughout 
the postoperative course, especially early after surgery, a policy of regular 
assessment of pain using simple measurement tools is the best way to ensure 
that pain treatment can be appropriately titrated. Pain is considered as the 
“fifth vital sign”32.  
Accurate assessment of post-operative pain is mandatory to ensure that pain 
is managed effectively. 
Tools for Evaluation of Pain
33
: 
Many pain scoring systems are available to assess the severity of pain. 
a) Categorical: This is a four or five point scale grading .The  pain is 
graded as none, mild, moderate, severe and excruciating. The disadvantage 
of this scale is, it lacks sensitivity, but the advantage is its simplicity. 
b) Numerical scale: This is an 11 point scale from 0 to 10. “0” means 
no pain. “10” is the worst imaginable pain. 
c) Visual Analogue Scale (VAS): This is a 100 mm scale. No pain at 
one end and at the other end worst imaginable pain at the other. Visual 
analogue scale is most commonly used.  
d) McGill Pain Questionnaire (MPQ): MPQ measures pain multi-
dimensionally. It measures affective, sensory, evaluative and other aspects 
of pain and its questionnaire contains about 20 aspects. 
 1 to 10 -sensory aspects of pain, 
 11 to 15 - affective aspect of pain,  
16 -evaluative aspect of pain,  
17 to 20 -miscellaneous aspects of pain. Each subunit has 2 to 5 points 
under them. The sum of all points gives a rank value, which is termed the 
Pain Rating Index. 
e) Happy-sad face –A set of faces that a child or an illiterate person 
can use to indicate the severity of his pain. This scale shows a child’s face in 
different moods. The person is asked to select the facial expression that best 
suites the pain expression to assess the affective and fear component of pain. 
 
 
 
 
 
 
                                           
                                      SEDATION 
The effective management of pain, sleep and anxiety are the main aims of a 
sedation therapy regimen. The management of pain is an important one in 
the management of sedation. Adequate post operative analgesia may reduce 
the necessity for other sedation therapy. 
Sedation Scoring Systems: 
Four sedation scoring systems are available. They are: 
1. The Ramsay Sedation Scale;  
2. The Sedation Agitation Scale;  
3. The Motor Activity Assessment Scale  
          4. The Comfort Scale [19] for the pediatric population: 
The Ramsay Sedation Scale: 
This was the first scale to be defined. It was designed as a test of 
arousability. The RSS score has six different levels, according to how 
arousable the patient is. It can be added to the pain score and should be 
considered the sixth vital sign. 
    
 
 
 
 Ramsay Sedation Scale 
  
Score Response 
1 Anxious, agitated or restless or both. 
2 Co operative, oriented, tranquil. 
3 Responding to commands only. 
4 Brisk response to light glabellar tap. 
5 Sluggish response to light glabellar tap. 
6 No response to light glabellar tap. 
 
Disadvantage of the RSS: 
1. Patients who have received neuromuscular blocking drugs cannot 
be assessed in this manner, since this scale relies on the ability of the patient 
to respond. 
2.  Level 1 score, there is no further definition of the degree of 
agitation. The Sedation-Agitation Scale is taken into consideration.  
3. In level 6 score, there is no further information as to whether the 
patient is in a lighter plane of general anesthesia or deep coma. This 
assessment can be monitored by spectral array signal from an EEG, A BIS 
index of 61.7 correlates well with a RSS of 6.                            
                               REVIEW OF LITERATURE 
 
1. G. Andrieu
  
et al H. Amrouni1, E. Robin1,
34
 studied the intra operative 
and post operative analgesic efficacy of BSCPB performed in patients 
undergoing  thyroidectomy under general anaesthesia , using ropivacaine or 
ropivacaine  with clonidine 5 µg/ml. During intraoperative period, the opioid 
requirements were reduced significantly in ropivacaine plus clonidine group.  
Systolic Blood Pressure was reduced significantly in Group RC (ropivacaine 
and clonidine) compared with the other groups at the end of surgery and at 
extubation. The maximum reduction in Systolic Blood Pressure with 
induction was 28% for Group RC (ropivacaine and clonidine) and 24% for 
Groups R (ropivacaine) and P (saline group). There was no difference in 
blood pressure between Groups R (ropivacaine only) and P (saline group). 
There was no difference in the heart rate between the groups. The 
requirement of Sulfentanil was reduced significantly in Group RC 
(ropivacaine and clonidine) compared with Groups P (saline group) and R 
(ropivacaine only) (P, 0.005). The requirements of Nefopam during the first 
24 h after surgery were reduced significantly in Groups R (ropivacaine only) 
and RC (ropivacaine and clonidine)  compared with Group P (control group) 
(P¼0.03), but there was no difference between R and RC. Group R 
(ropivacaine only) has less pain score median (range) 3 (0–10) 
(P¼0.01).Pain scores were significantly lower in RC (ropivacaine and 
clonidine)   3 (0–8) than in Group P (control group) 5(0–8) at admission into 
PACU. They concluded that, Bilateral Superficial cervical plexus block is a 
technique that effectively reduces intra operative and post operative 
analgesic requirements. The addition of clonidine with ropivacaine improves 
intraoperative and post operative analgesia.  
 
2. Ruth Landau et al 
35 
they studied the effects of clonidine with 
ropivacaine for labor analgesia through epidural route. They selected 66 
women in early labor. They were randomized to Group 1 to receive 
ropivacaine (0.1%) 8 mL plus clonidine 75mcg, Group 2 ropivacaine (0.2%) 
8 mL plus 0.5% normal saline and Group 3 ropivacaine (0.2%) 8 mL plus 
clonidine 75mcg. The duration of analgesia was increased in Group 1(132+ 
48 min) and in Group 3 (154+42 min) versus Group 2 (91+ 44 min) P < 
0.05). The total dose of ropivacaine in the first 4 hour was significantly 
reduced in Group 1(40.5 +15 mg) and Group 3 47.0 +16 mg) [versus in 
group 2(72.5+18 mg) P<0.01). The incidence of more profound motor block 
was more frequent in Group 2(P< 0.05). This study evaluated the effect of 
ropivacaine with adjuvant clonidine. 
3. Rita Pal et al 
36
 studied the analgesic efficacy of cervical plexus 
block using bupivacaine and clonidine. The duration of post operative 
analgesia was significantly higher in bupivacaine plus clonidine group (8.19 
± 3.2 hour) than in bupivacaine group (5.24 ±1.6 hours). In the bupivacaine 
plus clonidine group, total dosage of fentanyl in postoperative period was 
also significantly less.  
 
4. Sophie Aunac et al 
37
 studied the analgesic efficacy of superficial 
and deep cervical plexus block in patients undergoing thyroid surgeries 
under general anesthesia. Bilateral combined deep and superficial cervical 
plexus block was given with saline (Group 1), ropivacaine (Group 2), or 
ropivacaine with clonidine 7.5 μg/mL (Group 3). They observed that the 
number of additional alfentanil boluses during surgery was reduced 
significantly in Groups 2 and 3 compared with Group 1. The opioid and non-
opioid analgesic requirements after surgery were also reduced significantly 
in Groups 2 and 3 during the first 24 h. 
 
5. Danelli G et al
9
 evaluated the effects of ropivacaine 150mg with 
clonidine 50mcg for superficial cervical plexus block in patients undergoing 
elective carotid endarterectomy. They concluded that BSCPB improved the 
quality of anesthesia in patients undergoing elective carotid endarterectomy. 
 
6. Ming-Lang Shih et al 
38
 evaluated the post operative analgesic 
efficacy of BSCPB in patients undergoing thyroidectomy and to assess 
whether BSCPB reduced the side effects of general anesthesia. They 
concluded that it reduces requirements of general anesthetics during surgery. 
It also lowers the postoperative pain significantly during the first 24 hours. 
 
7. Nathalie Dieudonne et al 
39
evaluated the analgesic efficacy of 
BSCPB performed at the end of thyroid surgery using 20 mL normal saline 
or  bupivacaine 20 ml ( 0.25%) with epinephrine(1in 2L). The Bupivacaine 
group needed less morphine post operatively and lower initial median pain 
scores. It was concluded that BSCPB provides significant analgesia in the 
postoperative period after thyroid surgery. 
 
8.Rowan R. Molnar et al 
40compared the effect of clonidine 5 μg/mL 
with lignocaine 1.5% for cervical plexus blockade with the addition of 
epinephrine 5 μg/mL with lignoaine for carotid endarterectomy. The block 
onset time and duration were the same between the two groups. In the 
epinephrine group, the heart rate was increased significantly as compared 
with the clonidine group. They concluded that the addition of clonidine 5 
μg/mL to lidocaine 1.5% reduce the incidence of tachycardia in cervical 
plexus block 
 
9. Susmita Chakra borty et al 
41 
evaluated the efficacy of brachial 
plexus block using bupivacaine with clonidine. They concluded that duration 
of analgesia is prolonged when using bupivacaine with clonidine for brachial 
plexus block without producing any adverse reactions other than sedation. 
 
10. Giovanni Cucchiaro et al 
42 
studied the effects of clonidine in 
various peripheral nerve blocks in children on the duration of analgesic 
effect. The patients received either ropivacaine or other local anesthetic  and 
a combination of clonidine with ropivacaine or other local anesthetic .The 
duration of analgesia was significantly longer in the clonidine with local 
anaesthetics (17.2 ± 5 h) compared with that in the local anaesthetic group 
(13.2 ± 5 h). The increase in duration was not depending upon the local 
anesthetic used, type of peripheral nerve block, and operation performed. 
  
11. Andrea Casati et al 
43 
demonstrated that prolonged duration of 
analgesia with the addition of clonidine 1mcg/kg with ropivacaine 0.75%, 
when providing sciatic-femoral nerve block, with no hemodynamic adverse 
effects and mild increase in degree of sedation. 
 
12. H. El Saied et al 
44demonstrated that addition of 150 μg of 
clonidine to ropivacaine prolongs the duration of block and analgesia in a 
brachial plexus block, without any significant side effects. 
 
13. Brian D. Sites et al 
45
 studied the effects of intrathecal clonidine 
for total knee arthroplasty using a hyperbaric bupivacaine spinal anesthetic. 
It was concluded that the addition of intrathecal clonidine with morphine 
decreased analgesic requirements and morphine consumption. The 24 hour 
VAS score was less when compared with intrathecal morphine alone. 
14. Scott S. Reuben et al 
46 
studied the effect of clonidine in 
intravenous regional anesthesia with other local anaesthetics. They 
concluded that the addition of 1 µg/kg clonidine to lidocaine, 0.5%, for 
IVRA in patients undergoing ambulatory hand surgery improves 
postoperative analgesia without causing significant side effects during the 
first postoperative day. 
  
15. DJ Reinhart et al 
47 
compared the effect of lidocaine (1.73%) and 
clonidine (10mcg/ml) with lidocaine alone for peripheral nerve block for 
foot surgery .They concluded that addition of clonidine increases the 
duration and quality of postoperative analgesia significantly. 
 
16. Zeynep Eti et al
 48
, they compared the analgesic efficacy of 
BSCPB and local anesthetic wound infiltration after thyroidectomy.45 
patients were divided into 3 groups. Bilateral superficial cervical plexus 
block was performed after general anaesthesia, with 15 ml of bupivacaine 
(0.25%) in each side in Group I, and 20 ml of local anesthetic wound 
infiltration with bupivacaine (0.25%) in Group II. In Group III (control) no 
regional block was administered. Postoperative analgesic requirement was 
evaluated by intravenous patient-controlled analgesia. Visual analogue scale 
scores and total analgesic doses were same among groups. They concluded 
that BSCPB or infiltration of local anesthetic with bupivacaine (0.25%) did 
not reduce analgesic requirement after thyroid surgery. 
 
 
17. B. Vallet and  G. Lebuffe49 In this study 50 patients were 
randomized in to two groups, to receive either 20 mL of normal 
saline(Saline group) or 20 mL of 0.25% bupivacaine  (Bupivacaine group). 
BSCBs were performed before induction of general anaesthesia. Post 
operatively patients were transferred to the PACU. Morphine was 
administered in PACU if VAS score was more than 4. Post operative pain 
and all adverse effects were recorded at PACU. They assessed pain scores 
and amount of morphine required. 
The Bupivacaine group had less analgesic requirements (24% vs. 72%; P = 
0.0016). Patients who received BSCPB had significantly lower VAS. They 
concluded that BSCPB reduce pain intensity significantly and also reduces 
opioids requirement in the postoperative period after thyroid surgery.  
 
18. Isaak Kesisoglou, MD, PhD, Theodossis et al
50 
 
 
This study evaluated the effects of bilateral superficial cervical plexus block 
in 100 patients undergoing thyroidectomy. BSCPB was done with 20 ml of 
ropivacaine 0.75%.Precoxib was administered immediately and 12 hours 
postoperatively. Pain scores were recorded 0, 3, 6, 9, 12 and 24 hours after 
thyroidectomy. Pain score was higher in control group than ropivacaine 
group (p<.05). Analgesic requirements were equal in both groups. They 
concluded that BSCPB significantly reduce the post operative pain scores 
and has a major effect on post operative analgesia on patients after total 
thyroidectomy with no significant difference in analgesic requirements. 
 
                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                              MATERIALS AND METHODS 
 
This study was a Prospective, randomized, double blinded study conducted 
among 60 patients who were undergoing total thyroidectomy for 
multinodular goiter under General anaesthesia   at Rajiv Gandhi Government 
General Hospital, Chennai from 2010 to 2012. 
The study was approved by institutional ethical committee and informed 
consent was obtained from all the patients in the study. 
 
Selection of cases: 
Inclusion criteria: 
• Age        : 18 years to 60 years. 
• ASA        : I & II. 
• Surgery:  Elective. 
• Euthyroid state. 
• Who have given valid informed consent.  
 
 
 
 EXCLUSION CRITERIA: 
 
• Patients with   malignant thyroid disorders. 
• Patients with   retrosternal   goitre.  
• Coagulation   disorders. 
• Pregnancy. 
• Age < 18 yrs. 
• Patient refusal. 
• Patients with severe cardiovascular, respiratory, renal, hepatic 
diseases. 
• Emergency cases. 
• Patients with difficult airway. 
 
Pre operative thorough physical and clinical examination was done and   all 
the basic investigations verified. Airway assessment was done. 
Patients were randomized by closed envelope method into Group A, B and 
C. (Group A) to receive isotonic saline, (Group B) injection ropivacaine 
0.5% and (Group C) injection ropivacaine 0.5% and Clonidine 2mcg/kg. 
Patients in all the 3 groups were given general anesthesia. The base line 
heart rate, Blood pressure and Spo2 were recorded. All patients were 
preloaded with 10 ml/kg of normal saline and premedicated with injection 
Glycopyrrolate 0.2mgi.v. 
 
Induction was done with Inj. Fentanyl 2ug/kg, Inj. thiopentone 4mg/kg 
followed by inj.atracurium0.5 mg/kg and  intubated   with  endotracheal   
tube  of  appropriate  size,  maintenance  with  N20;02   2;1, sevoflurane 1%.    
The injection was given to Anaesthesiologist in unlabelled syringes. The 
specific injection given was not known to the patient, surgeon, 
anaesthesiologist and doctor involved in the assessment of pain score at 
PACU.   
 
Bilateral superficial cervical plexus block was performed by an anaesthetist 
who was familiar in this technique before induction and incision. 
Using three point injection technique 10 ml of prepared solution was 
injected in each sides of neck. 
A 23 gauge needle was inserted at the posterior border of 
sternocleidomastoid muscle, 2cm above the clavicle. The depth of the needle 
should be less than 5mm. 6ml of prepared mixture was given in cephalad 
direction, 2ml in the transverse direction. These two injections were for 
blocking the greater auricular and transverse cervical nerves. 2ml of 
injection at the needle puncture site to block the supra clavicular nerves. 
Intra operatively systolic blood pressure, diastolic blood pressure, heart rate 
and Spo2 were measured every 5 minutes up to 30 minutes and then every 
fifteen minutes till the surgery is over. Injection atracuriun 5 mg was given 
every 30 minutes.  Injection Fentanyl was given every 60 minutes and 
additional doses were administered for any variation in blood pressure and 
heart rate for group A. The duration of surgery and Fentanyl requirements 
were calculated. 
 
At the end of surgery patient was reversed with Inj. neostigmine 40- 
50mcg/kg and Inj Glyco 0.4mg i.v., and extubated after adequate 
neuromuscular recovery. Post operative laryngoscope was done for assessing 
vocal cord movements. 
Post operatively patient was shifted to PACU.  In PACU post operative pain 
score was assessed using visual analog score (VAS) and heart rate, systolic 
and diastolic blood pressure, mean arterial pressure and sedation score were 
recorded for  every 30minutes  upto 6 hours and every 4 hours upto 24 
hours. 
IV paracetamol infusion was administered 6
th
 hourly. Pain score was 
assessed at admission to PACU.  Injection Diclofenac sodium 75mg i.v 
infusion in  100ml  saline over  20  mins as  rescue  analgesia was given to 
patients with VAS score more than 5. 
 
 
                                
 
                                
 
 
 
 
 
 
 
 
 
 
 
 
                           OBSERVATION AND RESULTS 
All the enrolled 60 patients completed the study protocol. All the data were 
entered into Microsoft excel software and statistical analysis was done using 
SPSS Software version 15.0. 
Statistical analysis 
All parametric data were analyzed with chi square test, student t test. 
All non parametric data were analyzed with one way anova. 
The data analyzed were, 
1. Demographics and duration of surgery. 
2. Duration of post operative analgesia. 
3. Post operative VAS score. 
4. Rescue analgesia requirements. 
5. Total   dosage of fentanyl. 
6. Haemodynamic status during   preoperative Baseline, induction, 
intubation,   intra operative and post operative. 
7. Sedation score. 
8. Side effects. 
 
 
 
1. Demographics: 
Demographic characteristics like age, BMI were similar in all three groups  
 
except gender where female were predominant.  
 
Gender Distributions 
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 Group A Group B Group C P value 
   
Age 36.95+10.58 39.55+11.01 38.70+11.38 0.749 
BMI 21.94+ 0.85 21.99+0.8 22.44+0.84 0.393 
 
Gender Group A Group B Group C 
Female 19 (95%) 19(95%) 17(85%) 
Male 1(5%) 1(5%) 3(15%) 
 
Duration of surgery: 
 
 
  
Group  
 
P-value 
Group A(n=20) Group B(n=20) Group C(n=20) 
Mean + SD Mean + SD Mean+SD 
Duration of 
surgery 
 115.50 + 26.60    130.25+15.68 128.25+30.75 
 
   0.142 
 
Duration of surgery in group A was 115+ 26.60 minutes, Group B was  
130.25+15.68and in Group C was 128.25+30. There is no statistical 
difference in the duration of surgery among three groups. 
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2. Mean duration of analgesia: 
 
 
  
                                Group  
 
P-value 
Group A(n=20) Group B(n=20) Group C(n=20) 
Mean + SD Mean + SD Mean+SD 
Duration of 
analgesia(min
s) 
66.00+58.88    640.50+150.24 984.00+120.63 
 
<.001** 
                           
                      **- highly significant 
In group A 14 patients (70%) had pain at the time admission into PACU. In 
Group A the mean duration of analgesia was 66.00+58.88 minutes In Group 
B (ropivacaine 0.5%) the mean duration of analgesia was 640.50+150.24 
minutes. In Group C (ropivacaine 0.5% with clonidine) the mean duration of 
analgesia was 984.00+120.6 minutes. On comparing Group C with Group B 
the mean duration of analgesia is statistically highly significant (p value 
<.001). On comparing group C with group A the mean duration of analgesia 
in group C is statistically highly significant. 
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3. Visual Analogue Scale-Post operative: 
 
 PACU 
 Time(hrs) 
Group  
 
P-value 
Group A Group B Group C 
Mean SD Mean SD Mean SD 
O  5.85 2.03 1.85 .67 1.00 .22 <.001** 
½ hr 2.15 .93 1.90 .64 1.00 .22 <.001** 
1hr 2.25 .97 2.10 .45 1.00 .00 <.02* 
2hrs 2.70 1.26 2.30 .47 1.05 .22 <.001** 
4hrs 2.95 .60 2.95 .60 1.15 .37 <.001* 
6hrs 3.70 .57 3.20 .83 2.10 .85 <.001** 
10hrs 4.45 .51 3.75 1.12 2.75 1.07 <.001** 
14hrs 3.60 1.43 3.05 .39 2.35 1.36 <.001** 
18hrs 3.75 .91 3.45 .60 2.35 1.85 <.001** 
22hrs 3.75 .44 2.75 .55 1.80 .41 <.001** 
24hrs 3.95 .22 2.90 .45 2.00 .32 <.001** 
                                          *-Significant 
                                       **- highly significant 
 
  
Group  
 
P-value 
Group A(n=20) Group B(n=20) Group C(n=20) 
Median Median  Median 
At PACU 
VAS  6.5    2 1 
 
   
0.001** 
 
During postoperative period, the pain score was analyzed with Visual 
analogue scale. On comparing Group B and Group C with Group A, VAS 
pain score was less in Group B and Group C. The pain score was still lesser 
in Group C compared to Group B. The p-values are statistically highly 
significant between the groups. At admission into PACU the mean pain 
score in Group A was 5.85+ 2.03   , Group B was 1.85+0.67 and in Group C 
was 1+0.22. 
 
                               Visual Analogue Scale 
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4. Time of Rescue analgesia: 
 
 
  
Group  
 
P-value 
Group A(n=20) Group B(n=20) Group C(n=20) 
Mean + SD Mean + SD Mean+SD 
1.time of 1
st
 
Rescue(mins) 
  
66.00+58.88    448.50+127.83 996.00+140.91 
 
<.001 
    
2.Time of 2
nd
 
Rescue(mins) 
768.00+157.67              -             - 
 
                                    **- highly significant 
The mean time of first rescue analgesia in group A was 66.00+58.88, Group 
B was 448.50+127.83 and in group C was 996.00+140.91. The requirement 
of rescue analgesia in Group A was early in the post operative period when 
compared to Group B and Group C which is statistically significant. The 
time of first rescue analgesia was early in group B when compared to group 
C. 
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5. Intra operative Fentanyl dosage: 
 
 Group  
  Group A Group B Group C  
  Mean SD Mean SD Mean SD  
Fentanyl  133.00 13.42 100.00 .00 100.00 .00 <.001** 
                                                   **- highly significant 
The dosage of fentanyl for Group B and Group C was less than Group A 
which is statistically highly significant. The dosage of fentanyl  in group B 
and group C were same. 
 
 
6. Haemodynamics: 
 
a) Pre operative haemodynamics: 
 
 
 
Group  
 
P value 
Group A Group B Group C 
Mean SD Mean SD Mean SD 
Baseline 
SBP 133.40 31.92 139.45 18.33 143.50 8.60 .345 
DBP 90.25 8.53 86.60 9.66 91.20 5.94 .182 
MAP 107.30 9.39 104.35 10.70 108.40 6.72 .353 
HR 94.35 24.23 102.90 14.18 98.95 9.73 .296 
 
                           BASELINE Haemodynamics 
 
 
                  Group A                             Group B                        Group C 
 
 
 
At baseline level, no significant difference in the Systolic blood pressure 
(SBP), Diastolic blood pressure (DBP), mean arterial pressure (MAP) and 
heart rate (HR) between the three groups was found. 
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 b) Haemodynamic status at induction: 
 Group P value 
  Group A Group B Group C 
  Mean SD Mean SD Mean SD 
Inductio
n 
SBP 136.7
5 
18.50 124.35 12.95 123.55 7.23 
.005* 
DBP 89.40 12.47 80.15 7.98 83.90 4.92 .008* 
MAP 105.0
5 
14.15 94.20 9.68 97.05 4.84 
.004* 
HR 102.2
0 
13.84 91.05 11.81 87.55 6.95 
<.001** 
                        *- significant 
                      **- highly significant 
During induction period the difference in the Systolic blood pressure (SBP), 
Mean arterial pressure (MAP) and heart rate (HR) at induction and 
difference in the heart rate is highly significant between the three groups. 
 
c)  Haemodynamic status at the incision time: 
 Group  
 
P-value 
  Group A Group B Group C 
  Mean SD Mean SD Mean SD 
Incision SBP 123.75 16.25 112.35 10.90 113.85 7.18 .08 
DBP 84.80 12.87 76.60 7.46 79.65 6.86 .027* 
MAP 96.70 13.52 89.85 8.48 89.55 7.27 .49 
HR 91.15 23.68 80.85 9.15 75.90 7.67 .09 
                                   *-significant 
At the incision time the difference in the Systolic blood pressure (SBP), 
Diastolic blood pressure (DBP) and heart rate (HR) are statistically 
significant between the three groups.  
d) Haemodynamic status at the end of the procedure: 
 
 Group P-value 
  Group A Group B Group C 
  Mean SD Mean SD Mean SD 
End  
of  
proced
ure 
SBP 135.2
0 
11.45 118.45 9.19 115.15 10.06 
<.001** 
DB
P 
89.10 8.81 79.50 8.92 80.65 7.04 
.01* 
MA
P 
103.6
0 
9.38 91.95 8.40 91.95 7.87 
<.001** 
HR 89.50 16.10 75.85 9.89 71.55 8.50 <.001** 
                        *- significant 
                      **- highly significant 
 
At the end of the procedure the difference in the Systolic blood pressure 
(SBP), Diastolic blood pressure (DBP), mean arterial pressure (MAP) and 
heart rate (HR) are significant between the three groups. 
 
 
 
e) Haemodynamics during extubation: 
 Group P-value 
  Group A Group B Group C 
  Mean SD Mean SD Mean SD 
Ext
ubat
ion 
SBP 145.7
5 
11.45 128.00 8.90 128.60 6.62 
<.001** 
DBP 93.45 6.95 82.65 9.15 85.65 6.84 <.01* 
MAP 110.9
0 
6.49 96.75 9.22 99.25 7.03 
<.001** 
HR 103.7
0 
12.12 87.75 7.95 85.05 7.53 
<.01* 
  *-significant 
 **- highly significant 
At extubation the difference in the Systolic blood pressure (SBP), Diastolic 
blood pressure (DBP), mean arterial pressure (MAP) and heart rate (HR) are  
statistically significant between the three groups. 
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 4.  Intra operative Haemodynamics: 
  a) Systolic blood pressure:   
 Group  
 
P-value 
  Group A Group B Group C 
 Time(mins) Mean SD Mean SD Mean SD 
0 125.70 17.42 117.50 9.38 113.85 7.18 .010* 
15  126.55 17.80 111.25 10.96 112.65 8.86   .001* 
30 126.15 14.24 115.55 10.98 115.65 8.49  .006* 
45 124.40 11.55 117.50 10.99 117.50 8.58  .063 
60 124.30 10.67 117.45 10.98 116.15 7.82   .026* 
90 128.41 13.58 117.80 8.16 117.45 9.57 .003* 
120 135.07 14.50 119.84 9.97 117.39 10.21  < .001** 
150 148.13 9.49 126.77 6.66 121.00 10.09  < .001** 
                        *- significant 
                      **- highly significant 
During intra operative period, Systolic blood pressure was lower in group B 
and Group C than Group A. At 15
th
 minutes, 90
th
 minutes, 120
th
 minutes and 
150
th
 minutes the differences were statistically significant between the three 
groups. All systolic BP values are well above 110mm Hg in both group B 
and group C. 
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 b) Diastolic blood pressure: 
 Group  
 
P-value 
  Group A Group B Group C 
 Time(mins) Mean SD Mean SD Mean SD 
0 86.30 13.30 80.35 9.50 79.65 6.86 .087 
15  88.10 14.99 75.95 7.44 78.10 8.12 .002* 
30 85.35 10.86 78.25 7.14 76.95 9.35 .012* 
45 83.70 7.36 76.50 8.97 78.70 8.50 .025 
60 84.00 7.13 77.85 7.41 78.25 7.08 .015* 
90 86.65 9.84 78.15 6.59 77.55 9.64 .004* 
120 87.29 8.06 78.21 6.54 79.06 7.60 .002* 
150 92.13 5.62 80.15 8.38 82.33 9.24 .008* 
                                                     *- significant 
Diastolic blood pressure was comparatively lower in Group B and Group C 
than Group A. The differences were statistically significant at 15
th
 minutes, 
90th minutes and 120
th
 minutes between the three groups. 
 
 
 
 
 
 
 
 
                                  
                        DIASTOLIC BLOOD PRESSURE 
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c) Mean arterial pressure: 
 Group  
 
P-value 
  Group A Group B Group C 
 Time(mins) Mean SD Mean SD Mean SD 
0 98.40 13.55 91.55 8.03 89.55 7.27 .018* 
15  100.70 15.77 86.95 8.59 89.55 8.62 .001* 
30 97.75 12.56 90.30 8.05 88.85 10.01 .019* 
45 97.25 8.87 89.90 9.06 91.40 8.92 .029* 
60 97.15 7.75 90.45 7.78 90.50 7.51 .010* 
90 100.83 8.77 91.00 5.88 91.65 8.04 <.001** 
120 103.29 9.38 91.42 7.29 91.33 8.32 <.001** 
150 110.63 6.41 94.92 7.83 94.80 9.33 <.001** 
                                                     *- significant                     
                                                  **- highly significant 
Mean arterial pressure was comparatively lower in group B and Group C 
than Group A. The p-values at 15
th
, 90th, 120th and 150
th
 minutes were 
statistically significant between the three groups. All MAP values are well 
above 80 mm Hg in both group B and group C. 
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 7. Post operative Haemodynamics: 
d) Heart rate: 
 
 Group  
 
P-value 
  Group A Group B Group C 
 Time(mins) Mean SD Mean SD Mean SD 
0 96.15 15.08 84.15 11.35 75.90 7.67 <.001** 
15  89.15 14.89 76.95 8.22 73.20 7.69 <.001** 
30 86.25 17.25 78.15 8.42 71.20 7.70 .01* 
45 86.65 18.28 77.40 7.43 71.95 8.65 .02* 
60 84.50 18.46 77.75 9.61 72.10 8.47 .014 
90 85.18 16.85 75.15 8.40 71.90 8.91 .03* 
120 89.00 15.04 78.16 8.86 70.61 8.32 <.001** 
150 99.25 24.83 82.31 9.18 75.87 9.43 .02* 
                                                     *- significant                     
                                                  **- highly significant 
 
In comparison to Group A, Heart rate is lower in Group B and Group C. The 
differences in heart rate during intra operative period were statistically 
significant between the three groups.   
 
 
 
 
 
  
 
                                    Systolic blood pressure 
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a) Systolic blood pressure: 
 
 Group  
 
P-value 
  Group A Group B Group C 
 time Mean SD Mean SD Mean SD 
O minute 142.85 8.53 121.10 6.77 122.15 7.61 <.001** 
½ hr 138.40 7.82 120.05 4.78 117.80 7.60  <.01* 
1hr 135.45 8.33 119.95 6.49 117.45 8.67 <.001** 
2hrs 133.55 8.76 119.45 5.64 116.30 6.63 <.001** 
4hrs 134.70 10.28 120.45 5.33 115.00 5.90 <.001** 
6hrs 139.00 7.68 128.00 7.23 117.40 9.21 <.02* 
10hrs 142.65 8.07 124.65 8.76 120.90 8.93 <.001** 
14hrs 141.60 8.25 121.05 5.23 125.30 11.02 <.03* 
18hrs 139.35 8.36 120.10 5.06 128.85 7.84  <.001** 
22hrs 137.10 9.22 121.00 5.51 121.50 5.24 <.04* 
24hrs 137.25 9.05 122.30 5.38 120.60 4.45 <.001** 
                                                   *- significant                     
                                                  **- highly significant 
During post operative period, Systolic blood pressure was lower in group B 
and Group C than Group A. The differences are statistically significant 
between the three groups. All systolic BP values are well above 110mm Hg 
in both group B and group C. 
 
  
 
 
 
                                      Diastolic blood pressure 
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 b) Diastolic blood pressure: 
 Group  
 
P-value 
  Group A Group B Group C 
 time Mean SD Mean SD Mean SD 
O minute 93.15 4.88 79.90 6.58 80.75 7.23 <.001** 
½ hr 90.70 4.66 78.10 5.64 76.25 7.38 <.02* 
1hr 89.45 6.88 77.85 5.78 75.05 7.86 <.001** 
2hrs 88.85 6.41 77.25 5.06 73.65 6.66 <.001** 
4hrs 88.05 7.01 79.70 5.92 74.25 5.72 <.03* 
6hrs 90.65 5.25 84.20 6.45 74.30 6.50 <.001** 
10hrs 93.50 5.82 83.00 7.38 76.10 6.61 <.001** 
14hrs 93.00 5.40 80.60 5.94 82.20 9.16 <.04* 
18hrs 90.40 5.45 79.55 5.73 81.80 8.98 <.001** 
22hrs 90.20 5.38 79.10 6.06 77.65 6.16 <.001** 
24hrs 89.95 4.87 79.40 6.40 77.10 5.84 <.001** 
                                                   *- significant                     
                                                  **- highly significant 
 
During post operative period, Diastolic blood pressure was lower in group B 
and Group C than Group A. The differences are statistically significant 
between the three groups. 
 
 
 
 
 
C) Mean Arterial Pressure: 
 
 Group  
 
P-value 
  Group A Group B Group C 
 time Mean SD Mean SD Mean SD 
O minute 109.80 4.67 93.75 4.99 94.05 6.53 <.001** 
½ hr 106.60 4.15 92.05 4.55 89.65 7.05 <.03* 
1hr 104.80 6.06 91.25 4.59 89.05 7.52 <.001** 
2hrs 103.70 6.36 91.40 4.76 87.70 6.84 <.001** 
4hrs 103.60 6.81 93.25 4.79 87.80 5.69 <.02* 
6hrs 106.70 4.54 98.80 5.75 88.65 6.89 <.001** 
10hrs 109.80 5.53 96.90 6.65 91.15 6.78 <.001** 
14hrs 109.15 4.63 94.00 4.96 97.00 10.11 <.001** 
18hrs 106.75 4.85 92.85 4.93 97.50 7.87 <.03* 
22hrs 105.95 5.53 93.15 5.23 92.15 4.67 <.001** 
24hrs 105.75 5.53 93.55 5.52 92.25 4.48 <.001** 
                                                   *- significant                     
                                                  **- highly significant 
 
 
During post operative period, Mean arterial pressure was lower in group B 
and Group C than Group A. The differences are statistically significant 
between the three groups. All MAP values are well above 80mm Hg in both 
group B and group C. 
d) Heart rate: 
 
 Group  
 
P-value 
  Group A Group B Group C 
 time Mean SD Mean SD Mean SD 
O minute 101.90 10.75 79.65 7.94 81.26 7.29 <.001** 
½ hr 95.20 9.27 78.20 6.82 78.89 6.01 <.04* 
1hr 94.05 8.00 76.05 6.69 76.53 6.53 <.001** 
2hrs 91.55 5.87 74.35 6.58 73.11 7.42 <.001** 
4hrs 90.55 6.73 75.00 6.91 73.42 6.89 <.001** 
6hrs 93.65 6.47 83.60 9.17 73.11 6.76 <.02* 
10hrs 98.75 7.81 81.95 7.71 75.16 7.62 <.001** 
14hrs 95.00 9.52 79.60 5.23 81.95 9.61 <.02* 
18hrs 92.90 5.81 80.05 4.35 82.16 8.06 <.001** 
22hrs 91.15 5.67 80.30 5.82 76.42 4.96 <.001** 
24hrs 91.35 6.12 79.90 5.24 75.53 4.14 <.03* 
                                                   *- significant                     
                                                  **- highly significant 
During post operative period, Heart rate was lower in group B and Group C 
than Group A the differences are statistically significant between the three 
groups. 
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SIDE EFFECTS: 
 
 Group A Group B Group C 
PONV 7(35%) 1(5%) 1(5%) 
Hypotension - - - 
Bradycardia - - 1(5%) 
Sedation - - 2(10%) 
 
In group A seven patients had nausea and vomiting post operatively whereas 
only one patient had PONV in group B and Group C. In group C one patient 
developed braycardia which was treated with injection atropine and two 
patients had mild sedation. 
 
 
 
 
 
 
 
 
 
 
                                            DISCUSSION 
 
 
Post thyroidectomy pain has many components which are related to the 
superficial and deep layers of the wound, wound drainage and neck position 
during the intra operative period. In different types of surgery local 
anaesthetics have been used as an infiltrating agent for post operative pain 
relief, but results were disappointing in procedures like Gynecological 
surgery, major visceral surgery and cervical spine surgery because of the 
short duration of action of local anaesthetics. 
       The demographic profile of our patients was comparable in all three 
groups with respect to mean age, BMI, ASA Physical status. There is no 
difference in the duration of surgery among  the three  groups.  
DURATION OF ANALGESIA: 
 
The results of the study showed that, BSCPB performed by three point 
technique before general anaesthesia using injection ropivacaine 0.5% 
(group B) and ropivacaine0.5% with clonidine 2mcg/kg (Group C) resulted 
in significant increase in the duration of post operative analgesia and 
reduction in other  post operative analgesic requirements. The addition of 
adjuvant clonidine 2mcg/kg to ropivacaine 0.5% prolongs the duration of 
post operative analgesia more than using ropivacaine 0.5% alone. An 
adjuvant clonidine with ropivacaine enhances pain relief after superficial 
cervical plexus block via central action through systemic absorption and 
direct action is mainly because of local nerve fibres involvement. 
In a study by Aunac S, Carlier M
11
, reported a reduction in analgesic 
requirement with BSCPB during intra operative and post operative periods 
for patients undergoing thyroidectomy under general anaesthesia done with 
0.5% ropivacaine and 0.5% ropivacaine with clonidine. During surgery, the 
requirement of additional alfentanil boluses was reduced significantly in 
Groups 2 and 3 compared with Group 1. After surgery, the opioid and 
NSAID analgesic requirements were also significantly reduced in Groups 2 
and 3 during the first 24 h. This correlates with the finding in our study.  
Susmita Chakra borty et al
41 
evaluated the effect of adjuvant 
clonidine with bupivacaine-induced supraclavicular brachial plexus block. 
They concluded that addition of a small dose of clonidine to 0.5% 
bupivacaine significantly prolonged the duration of analgesia without 
producing any clinically important adverse reactions other than sedation. 
In our study also the addition of clonidine with ropivacaine 
significantly prolonged the duration of analgesia (984+120.63 mins) when 
compared to control group (66+58.8 mins) 
 
El Saied AH, Steyn MP, Ansermino JM44 
The clonidine patients showed an increase in duration of sensory loss from 
489 min to 628 min with a mean difference of 138 min and analgesia from 
587 min to 828 min with mean difference of 241 min. There was no 
difference in onset time. No side effects were noted. 
The adjuvant of 150 microgram of clonidine to ropivacaine, for brachial 
plexus blockade, prolongs motor and sensory block and analgesia, without 
side effects. 
In our study, the addition of clonidine with ropivacaine increases the 
duration of analgesia in group C 984+120 mins and in group A was 66+ 58 
mins 
In a study by Herbland and colleagues 
8
, BSCPB performed by two point 
injection   with ropivacaine 0.75% administered before surgery without any 
adjuvant. As a consequence, in the post operative period the BSCPB may 
have receded rapidly, even though the duration of post operative analgesia is 
longer than local anaesthetic infiltration and control group.  
In our study since we used clonidine as an adjuvant, duration of post 
operative analgesia is longer than Group B and control group. 
 
 
PAIN SCORE: 
 
 
The VAS scores in group A confirm that after surgery, some patients 
experience severe pain after admission into PACU. The  mean visual  
analogue scale for  group B(1.85+ 0.67)and  group C(1.00+0.22) was  lower  
than  group A(5.85+ 2.03).On comparing  with group B,  group C  had  less 
mean  visual  analogue scale.After thyroidectomy, the initial post  operative 
period is very  important for  pain management. Acetaminophen alone is 
insufficient.  
In a study by Andrieu et al 
34
, At PACU admission, pain scores were  lower 
in Group R (Ropivacaine) median range 3 and RC (ropivacaine with 
clonidine)  is  median 3(0-8)   than in Group P (control) 5(0–8) .Pain score is  
reduced in all three groups during first 24 h after surgery. 
In our study Pain scores were lower in group C (ropivacaine with clonidine) 
with median 1 and Group B (ropivacaine alone) was median 2 when 
compared to group A (control) median 6.5.  
Hisham Negmi MD, et all  
 
At admission to PACU, patients given BSCBs had significantly lower VAS 
score than control group with mean 47 ± 19, 27 ± 17 mm respectively (p= 
0.002). 
This is comparable with our study, where mean VAS in group C was 
1.00+0.22 and in group A was 5.85+2.03. 
 
 
 
Isaak Kesisoglou, MD, PhD, et al 
50 
 
This study in 100 patients undergoing total thyroidectomy evaluated the 
effects of BSCPB done with 20ml of 0.75% ropivacaine. Additional 
parecoxib was administrated immediately postoperatively and 12 hours later.                                                                                                          
Postoperative pain was assessed by VAS. All parameters were recorded at 0, 
3, 6, 9, 12, and 24 hours after surgery. They concluded that two-point 
bilateral BSCPB has a major analgesic effect on patients after total 
thyroidectomy, with a significant statistical reduction in postoperative pain 
scores. 
In our study we also recorded all the parameters up to 24 hours post 
operatively. There was significant reduction in pain scores in patients whom 
BSCPB was performed (three point technique). 
 
Rescue analgesia: 
The group C and group B showed comparatively good results over group A 
in various characteristics like prolonged post operative analgesia and a 
decreased amount of rescue analgesia used post operatively. The mean time 
for first rescue analgesia was longer in Group C (996.00+140.91 minutes) 
and Group B   (448.50+127.83) when compared to Group A 
(66.00+58.88minutes).There was no second rescue in Group B and group C.  
The total analgesic requirement in group C was less when compared 
to group A. On comparing with Group B with Group C decreased the 
analgesic requirements were same post operatively. 
In a study by Andrieu et al
34
, Nefopam need during the first 24 h after 
thyroidectomy were significantly reduced in Group R (ropivacaine) and 
RC(ropivacaine  with clonidine) compared with Group P(control) , but no 
difference was observed between R and RC. 
In our study the analgesic requirements in group C and group B were 
significantly reduced when compared to group A. There was no second 
rescue in group C and group B. 
 
In study by Hisham Negmi MD, et al,  
 
In PACU the morphine consumption was significantly higher in control 
group compared to BSCBs group with mean 10.36 ± 6.7, 3.16 ± 5.85 mg 
respectively. Eighteen Patients in control group (72%) received morphine in 
PACU compared to 6 patients in BSCBs group (24%).  
In our study we used Inj. Diclofenac sodium as rescue analgesia .In group A 
14 patients (70%) required first rescue at the time of admission into PACU 
and none of the patient in group B and group C required rescue immediately. 
The total rescue dosage was higher in group A when compared to group B 
and group C. 
Hemodynamic stability: 
 
     Vital signs   remained stable throughout the intraoperative and post 
operative period, which confirms the established effects of α-2 agonists- 
clonidine in providing hemodynamically stability. Although a slight 
decrease in heart rate and blood pressure (both systolic and diastolic) was 
observed in the group C, it never fell down to more than 20% of baseline 
values.  
G. Andrieu
  
et al 
34 
in their study showed that systolic blood pressure 
was significantly lower in ropivacaine plus clonidine Group compared with 
ropivacaine only group at the end of resection and at extubation. The 
maximum reduction in systolic blood pressure compared with induction was 
28% for ropivacaine plus clonidine Group and 24% for ropivacaine only 
group.  
In our study there was significant reduction in systolic blood pressure, 
Diastolic blood pressure and heart rate during induction, extubation and 
throughout the intra and post operative period. 
 
Total Fentanyl Dosage: 
Total fentanyl dosage during intraoperative period is less in group B and 
Group C. Because of increased  intra operative opioid usage  in group A, 
some of  the patients  had  post operative vomiting  and sedation. By using 
regional anaesthesia technique like BSCPB, we can overcome this  problem 
In a study by Andrieu et al 
34
, where BSCPB was performed for 
thyroidectomy the intra operative total fentanyl dosage reduced significantly 
in Group RC compared with Groups P and R.   
In our study the total fentanyl  requirements significantly higher for control 
group when compared  to  BSCPB group. 
Hisham Negmi MD, et al 
 
Intraoperative fentanyl requirements were significantly higher in control 
group compared to BSCBs group with mean165 ± 51, 67.4 ± 17.8 mcg 
respectively. 
In our study also the total intra operative fentanyl dosage were significantly 
higher in control group (133 + 13.42)when compared with BSCPB group 
(100.00) 
Rita Pal et al 
35
 studied the quality and duration of postoperative 
analgesia by cervical plexus block using bupivacaine and clonidine. 
Duration of analgesia was significantly more in bupivacaine plus clonidine 
group (8.19 ± 3.2 hour) as compared to bupivacaine group (5.24 ±1.6 hours). 
Total consumption of fentanyl citrate in postoperative period was also 
significantly less in the bupivacaine plus clonidine group.  
In our study also the total intra operative fentanyl dosage were significantly 
higher in control group(133 + 13.42)when compared with BSCPB group 
(100.00) 
 
SEDATION SCORE: 
The results of our study showed that Ramsay sedation score in all the 
three groups are similar except in Group C, two patients had RSS of 3. 
Sedation in Group C is due to the effect of Clonidine. 
Andrea Casati et al 
43 
demonstrated that, when providing combined 
sciatic-femoral nerve block for hallux valgus repair, the addition of 1 μg/kg 
clonidine to 0.75% ropivacaine prolongs the duration of postoperative 
analgesia by 3 h, with only a slight and short-lived increase in the degree of 
sedation and no hemodynamic adverse effects. 
In our study two patients (10%) in group C had sedation without any 
adverse effects. 
 
SIDE EFFECTS: 
In group A seven patients had nausea and vomiting post operatively 
whereas one patient had PONV in group B and Group C. This correlates 
with higher dose of Fentanyl in Group A 
 
In a study by Andrieu  et al 
34
 patients (36%) developed PONV, 8 patients in 
Group P (control), 14 patients in Group R(ropivacaine), and 9 patients in 
Group RC (ropivacaine with clonidine).  
In contrast, in our study 35% of patients in the group A (control) and one 
patient in group (ropivacaine) and group C (ropivacaine with clonidine) had 
vomiting. 
Andrea Casati et al 
43 
demonstrated that prolonged duration of 
analgesia with the addition of clonidine 1mcg/kg with ropivacaine 0.75%, 
when providing combined sciatic-femoral nerve block for hallux valgus 
repair, with no hemodynamic adverse effects and mild increase in degree of 
sedation. 
In our study two patients (10%) in group C had sedation without any 
adverse effects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                     SUMMARY 
1. Duration of Analgesia: 
BSCPB performed by three point technique before general anaesthesia 
resulted in significant increase in the duration of post operative analgesia 
and reduction in other  post operative analgesic requirements. The addition 
of adjuvant clonidine 2mcg/kg to ropivacaine 0.5% prolongs the duration of 
post operative analgesia more than using ropivacaine 0.5% alone. 
2. Pain Score: 
At admission into PACU, the median VAS score is less in BSCPB patients. 
The pain score was still lesser in patients who received ropivacaine with 
clonidine. 
3. Rescue analgesia: 
Post operative analgesic requirements were significantly reduced in BSCPB 
group. 
4. Total Fentanyl dosage: 
There was significant reduction in intra operative fentanyl dosage in BSCPB 
groups. 
5. Haemodynamic status: 
There was reduction in Systolic blood pressure, Mean arterial pressure and 
Heart rate during intra and post operative period and it never fell down 
<20% of baseline value. 
6. Side effects: 
There was significant reduction in Post operative nausea and vomiting in 
BSCPB groups.  
 
 
 
 
 
 
 
 
    
 
 
 
 
                      CONCLUSION 
 
Bilateral Superficial cervical plexus block performed prior to general 
anaethesia using  ropivacaine 0.5% along with adjuvant clonidine 2mcg/kg 
had better post operative analgesic efficacy than ropivacaine alone in 
patients undergoing total thyroidectomy. It also reduces the intra operative 
opiates requirement, post operative rescue analgesia requirement and has 
lower VAS score with negligible side effects. From this study, we conclude 
that bilateral superficial cervical plexus block is an effective and useful 
method to manage post operative pain in patients undergoing total 
thyroidectomy. 
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3 D structure of Ropivacaine 
